Literature DB >> 17497756

Functional results after extended myotomy for diffuse oesophageal spasm.

M Leconte1, R Douard, M Gaudric, I Dumontier, S Chaussade, B Dousset.   

Abstract

BACKGROUND: The role of surgery in the management of patients with diffuse oesophageal spasm (DOS) remains controversial. The aim of this study was to assess functional results after extended myotomy for DOS.
METHODS: This prospective study evaluated 20 patients who had extended myotomy (14 cm on the oesophagus and 2 cm below the oesophagogastric junction) with anterior fundoplication via a laparotomy for severe DOS. Median follow-up was 50 (range 6-84) months. Functional data were assessed by means of dysphagia (range 0-3), chest pain (range 0-3) and overall clinical (range 0-12, including dysphagia, chest pain, regurgitation, gastro-oesophageal reflux) scores.
RESULTS: All patients had severe DOS. The median preoperative overall clinical score was 6 (range 3-8) with a dysphagia score of at least 2. Median postoperative functional scores were significantly lower than preoperative values (overall clinical score 1 versus 6, dysphagia score 0 versus 3, chest pain score 0 versus 2). At final follow-up, good or excellent results were obtained for overall clinical score in 16 patients, for dysphagia score in 18 and for chest pain score in all 20 patients. Postoperative gastro-oesophageal reflux was noted in two of the 20 patients.
CONCLUSION: Extended myotomy with anterior fundoplication is an effective treatment for severe DOS. Medium-term postoperative functional results were excellent, especially in terms of dysphagia and chest pain. Copyright (c) 2007 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17497756     DOI: 10.1002/bjs.5761

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

Review 1.  Distal esophageal spasm.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  Dysphagia       Date:  2012-01-04       Impact factor: 3.438

Review 2.  A comprehensive appraisal of the surgical treatment of diffuse esophageal spasm.

Authors:  Cristina Almansa; Ronald A Hinder; C Daniel Smith; Sami R Achem
Journal:  J Gastrointest Surg       Date:  2007-12-11       Impact factor: 3.452

Review 3.  Distal esophageal spasm: an update.

Authors:  Sami R Achem; Lauren B Gerson
Journal:  Curr Gastroenterol Rep       Date:  2013-09

4.  Clinical efficacy of per-oral endoscopic myotomy (POEM) for spastic esophageal disorders: a systematic review and meta-analysis.

Authors:  Saurabh Chandan; Babu Pappu Mohan; Ojasvini Choudhry Chandan; Lokesh Kumar Jha; Harmeet Singh Mashiana; Alexander Todd Hewlett; Mouen A Khashab
Journal:  Surg Endosc       Date:  2019-05-09       Impact factor: 4.584

5.  Esophagogastric junction outflow obstruction-related functional chest pain treated using robotic-assisted thoracoscopic esophageal myotomy.

Authors:  Kuan-Hsun Lin; Shih-Chun Lee; Tsai-Wang Huang; Hsu-Kai Huang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 6.  Peroral endoscopic myotomy: an evolving treatment for achalasia.

Authors:  Robert Bechara; Haruo Ikeda; Haruhiro Inoue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-02       Impact factor: 46.802

Review 7.  Therapeutic options in oesophageal dysphagia.

Authors:  Jan Tack; Giovanni Zaninotto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

Review 8.  Surgical treatment of primary esophageal motility disorders.

Authors:  Fernando A Herbella; Ana C Tineli; Jorge L Wilson; Jose C Del Grande
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

Review 9.  The Relevance of Spastic Esophageal Disorders as a Diagnostic Category.

Authors:  Michelle P Clermont; Nitin K Ahuja
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06

Review 10.  Management of spastic disorders of the esophagus.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  Gastroenterol Clin North Am       Date:  2013-01-04       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.